PAGANO, BENEDETTA
 Distribuzione geografica
Continente #
EU - Europa 538
NA - Nord America 485
AS - Asia 155
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.180
Nazione #
US - Stati Uniti d'America 483
IE - Irlanda 175
SE - Svezia 145
IT - Italia 80
CN - Cina 71
SG - Singapore 43
PL - Polonia 36
DE - Germania 31
IN - India 28
UA - Ucraina 16
FI - Finlandia 14
BE - Belgio 11
GB - Regno Unito 10
FR - Francia 9
IR - Iran 5
VN - Vietnam 4
AT - Austria 3
ES - Italia 3
ID - Indonesia 3
CA - Canada 2
EU - Europa 2
RU - Federazione Russa 2
CZ - Repubblica Ceca 1
HK - Hong Kong 1
LT - Lituania 1
NL - Olanda 1
Totale 1.180
Città #
Dublin 173
Chandler 156
Nyköping 109
Jacksonville 38
Warsaw 36
Ashburn 31
Singapore 31
Beijing 30
Princeton 27
Messina 23
Hyderabad 20
Bremen 19
Medford 19
Des Moines 17
Brussels 11
Rome 11
Boardman 9
Ann Arbor 8
Cambridge 8
Dearborn 8
Helsinki 8
Jinan 5
San Mateo 5
Zhengzhou 5
Augusta 4
Dong Ket 4
Redwood City 4
Waverly Hall 4
Ardabil 3
Jakarta 3
Los Angeles 3
Milan 3
Mislata 3
Monmouth Junction 3
Nanchang 3
Nanjing 3
Pune 3
Rometta Marea 3
Santa Domenica 3
Tianjin 3
Torregrotta 3
Vienna 3
Wilmington 3
Brooklyn 2
Clearwater 2
Clifton 2
Hangzhou 2
Leawood 2
London 2
Munich 2
New York 2
Ningbo 2
Pleasant Hill 2
Pozzo Di Gotto 2
Pozzuoli 2
Quinto Di Treviso 2
Reggio Calabria 2
Shenyang 2
Taiyuan 2
Taizhou 2
Berlin 1
Brno 1
Castelnuovo Rangone 1
Catania 1
Changsha 1
Chengdu 1
Duncan 1
Edinburgh 1
Guangzhou 1
Haikou 1
Hebei 1
Hefei 1
Hong Kong 1
Jian 1
Lancaster 1
Maple Ridge 1
Meppel 1
Newark 1
Norwalk 1
Nuremberg 1
Palo Alto 1
Pescara 1
Saint Petersburg 1
Santa Teresa Di Riva 1
Shenzhen 1
Stanford 1
Torino 1
Toronto 1
Wuhan 1
Totale 931
Nome #
PRRT Retreatments: Renal Function Evaluation 91
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 82
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 77
Design and synthesis of acetylcholinesterase inhibitors 71
Safety, effectiveness and haematological toxicity of 223Radichloride: a single Centre experience 69
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 69
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 67
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience 66
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 62
Renal Function Evaluation in PRRT Retreatments 62
Clinico-laboratory response and haematological toxicity in patients undergoing therapy with 223RA-dichloride 60
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 60
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience 59
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 58
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 58
Study of the production yields of 18F, 11C, 13N and 15O positron emitters from plasma-laser proton sources at ELI-Beamlines for labeling of PET radiopharmaceuticals 53
Theranosticsin nuclear medicine and oncology 52
Evaluation of the production capabilities of 18F, 11C, 13N and 15O PET isotopes at the PET-cyclotron-radiochemistry site of Messina University 46
Radiopharmaceuticals for Bone Metastases 44
Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics 21
Totale 1.227
Categoria #
all - tutte 6.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.033


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 0 0 9 8 7 1 25 9 18
2020/2021184 19 5 46 8 20 10 8 12 8 16 23 9
2021/2022159 2 17 2 5 9 2 4 11 4 14 17 72
2022/2023536 43 76 29 43 44 42 17 18 196 10 14 4
2023/2024126 5 16 5 7 13 26 2 13 0 20 5 14
2024/202579 6 6 15 26 26 0 0 0 0 0 0 0
Totale 1.227